Login

Financial Snapshot

Revenue
TTM
$238.1M
Gross Margin
TTM
75.0%
Net Income
TTM
-$31.45M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
710.06%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$244.8M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$7.834M

Stock Price

Loading...
Market Cap: $2.0984 Billion

About AxoGen Inc

AxoGen Inc (NASDAQ: AXGN) is a medical technology company focused on the surgical repair of peripheral nerves. The filing excerpts provided do not contain sufficient detail to describe AxoGen's revenue model, segment breakdown, customer base, competitive position, geographic footprint, or leadership with source-grounded specificity. The cover page of the 10-K filed 2026-02-24 (accession 000080592826000031) confirms AxoGen as the registrant and a well-known seasoned issuer, but the excerpts truncate before any business description, financial data, or operational detail is disclosed. No further factual claims about the company's products, markets, competitors, or financials can be made from the available filing content.

Source: SEC 10-K, filed 2026-02-24

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories Artivion Inc Senseonics Holdings Inc Cardiovascular Systems Inc Cue Health Inc. Vicarious Surgical Inc Inogen Inc Orthofix Medical Inc SI-BONE Inc SURMODICS INC

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support